However, downregulation of SETDB1 was also found in metastatic lung cancer [12,13,115,116,117], less aggressive osteosarcomas [21] and AML [68,69,74,118,119,120], indicating a tumour suppressive role of SETDB1 in different cancer types and stages. This evidence concerns the gene SETDB1 and acute myeloid leukemia.